𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: Relationships with prognosis

✍ Scribed by Fernanda C. G. Sampaio-Góes; Denise T. Oliveira; Regina G. Dorta; Suely Nonogaki; Gilles Landman; Inês N. Nishimoto; Luiz P. Kowalski


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
778 KB
Volume
27
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Background. The aim of this study was to compare the clinical features and proliferating cell nuclear antigen (PCNA), p53, Bcl-X, and Bax expression in primary oral basaloid squamous cell carcinoma (BSCC) and poorly differentiated squamous cell carcinoma (PDSCC) matched by stage and site and to assess the possible prognostic significance of these variables.

Methods. Seventeen cases of oral BSCC were compared with 27 PDSCCs matched by stage and tumor site. In addition, PCNA, p53, Bax, and Bcl-X expression in both carcinomas were evaluated in relation to their clinicopathologic features and prognostic values using the Kaplan -Meier method and Cox regression models.

Results. No statistically significant differences were found between the groups (BSCC and PDSCC) in regard to clinical features and immunohistochemical reactivity for antibodies PCNA, p53, and Bcl-X. In comparison with PDSCC, the BSCC group exhibited a higher Bax score (p = .031). The 5-year and 10year overall survival, cancer-specific survival, and disease-free survival rates demonstrated no significant differences between the BSCC and PDSCC groups, and the PCNA, p53, Bax, and Bcl-X also showed no prognostic value.

Conclusions. These results suggest that the clinical and biologic course of BSCC is similar to PDSCC in the oral cavity when clinical stage and site are matched.


📜 SIMILAR VOLUMES


The prognostic value of spontaneous apop
✍ Xin Xie; Ole Petter F. Clausen; Paula De Angelis; Morten Boysen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

BACKGROUND. Bax, Bcl-2, and p53 proteins are involved in the regulation of apoptosis and have been reported to correlate with prognosis in several tumor types. ## METHODS. Bax, Bcl-2, p53, and the level of spontaneous apoptosis were evaluated in formalin fixed, paraffin embedded pretreatment speci

Expression of p53 in oral squamous cell
✍ Saman Warnakulasuriya; Thierry Soussi; Rehana Maher; Newell Johnson; Mahvash Tav 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Around 50% of head and neck cancers are known to have aberrations of the p53 gene. Overexpression of the mutant p53 protein can induce a specific humoral response in cancer patients. Matched saliva, serum, and tissue samples from 26 patients with histologically confirmed oral squamous and verrucous

Mutation of p53 in head and neck squamou
✍ Genevieve A. Andrews; Sichuan Xi; Rebecca G. Pomerantz; Charles J. Lin; William 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

## Abstract ## Background. The p53 protein, a well‐known tumor suppressor that functions primarily as a transcription factor, initiates cell cycle arrest and apoptosis after genotoxic stress. The antiapoptotic regulator Bcl‐2 is a downstream modulator of p53‐induced apoptosis. Loss of function of